We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

Back to rankings

72 hedge funds and large institutions have $543M invested in Loxo Oncology, Inc in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 16 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 16

13% more capital invested

Capital invested by funds: $479M → $543M (+$64.2M)

0% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 8

1% less funds holding

Funds holding: 73 → 72 (-1)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
72
Holders Change
-1
Holders Change %
-1.37%
% of All Funds
1.92%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
8
Increased
34
Reduced
16
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
+$42.1M
2
PC
Paulson & Co
New York
+$12.7M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$8.2M
4
OM
Opaleye Management
Massachusetts
+$2.88M
5
AG
Artal Group
Luxembourg
+$1.96M

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$13.2M
2
O
OrbiMed
New York
-$11.7M
3
EI
EAM Investors
California
-$3M
4
Axa
Axa
France
-$1.61M
5
Ameriprise
Ameriprise
Minnesota
-$1.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Aisling Capital
New York
$105M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$85.1M +$1.3M +49,793 +2%
O
3
OrbiMed
New York
$45.2M -$11.7M -447,857 -21%
Victory Capital Management
4
Victory Capital Management
Texas
$42.2M +$42.1M +1,610,334 New
Wellington Management Group
5
Wellington Management Group
Massachusetts
$41.9M +$8.2M +313,428 +24%
NMC
6
NEA Management Company
Maryland
$33.8M -$13.2M -502,787 -28%
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$21.4M – – –
EAM
8
Eventide Asset Management
Massachusetts
$19.4M – – –
PC
9
Paulson & Co
New York
$19.3M +$12.7M +486,600 +194%
Vanguard Group
10
Vanguard Group
Pennsylvania
$13.2M +$153K +5,858 +1%
BFA
11
BlackRock Fund Advisors
California
$9.65M +$614K +23,483 +7%
DCM
12
Driehaus Capital Management
Illinois
$8.97M +$726K +27,741 +9%
CC
13
Casdin Capital
New York
$7.62M -$235K -9,000 -3%
Franklin Resources
14
Franklin Resources
California
$7.2M – – –
Capital World Investors
15
Capital World Investors
California
$6.86M – – –
DM
16
Deerfield Management
New York
$6.57M – – –
BIT
17
BlackRock Institutional Trust
California
$6.27M +$631K +24,121 +11%
UBS AM
18
UBS AM
Illinois
$6.04M +$562K +21,477 +10%
State Street
19
State Street
Massachusetts
$5.5M +$234K +8,940 +4%
Axa
20
Axa
France
$5.21M -$1.61M -61,473 -24%
AIC
21
AWM Investment Company
New York
$4.71M -$262K -10,000 -5%
Northern Trust
22
Northern Trust
Illinois
$4.22M -$95.9K -3,666 -2%
BBA
23
Baker Bros. Advisors
New York
$3.61M – – –
DCM
24
DAFNA Capital Management
California
$3.41M +$739K +28,256 +28%
OM
25
Opaleye Management
Massachusetts
$2.88M +$2.88M +110,000 New
1
2 3 4

LOXO Hedge Fund Activity: Q3 2016 in Review

72 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q3 2016, worth a combined $543M — up 13% from $479M a quarter earlier.

Fund positioning in LOXO was balanced in Q3 2016: 8 funds opened new positions, 8 closed out, 34 added to existing stakes and 16 trimmed.

The largest buyer was Victory Capital Management, opening a new position worth an estimated $42.1M. The largest seller was NEA Management Company, cutting an estimated $13.2M.

  • 72 institutional investors held Loxo Oncology, Inc (LOXO) as of Q3 2016, down from 73 in Q2 2016.
  • Funds reported $543M of Loxo Oncology, Inc stock for Q3 2016, up 13% quarter-over-quarter.
  • 8 funds opened new Loxo Oncology, Inc positions in Q3 2016 and 8 closed out, a net change of 0 holders.
  • The largest Loxo Oncology, Inc buyer in Q3 2016 was Victory Capital Management, an estimated $42.1M added.
  • The largest Loxo Oncology, Inc seller in Q3 2016 was NEA Management Company, an estimated $13.2M sold.

Based on aggregated 13F filings for Q3 2016.